ChiCTR2200056405 版本V1.1 版本创建时间2024/09/24 11:36:19 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200056405 

最近更新日期:

Date of Last Refreshed on:

2023-02-26 23:54:03 

注册时间:

Date of Registration:

2022-02-05 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

此为补注册,需在www.medresman.org.cn上建立项目、审核原始数据并公示后才能补注册 分子诊断在单基因致病型低钾血症中的应用

Public title:

Application of molecular diagnosis in monogenic hypokalemia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

分子诊断在单基因致病型低钾血症中的应用

Scientific title:

Application of molecular diagnosis in monogenic hypokalemia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张馨月 

研究负责人:

童南伟 

Applicant:

Xinyue Zhang 

Study leader:

Nanwei Tong 

申请注册联系人电话:

Applicant telephone:

18780235998

研究负责人电话:

Study leader's telephone:

18980601196

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

314712576@qq.com

研究负责人电子邮件:

Study leader's E-mail:

tongnw@scu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省成都市武侯区国学巷37号

研究负责人通讯地址:

四川省成都市武侯区国学巷37号

Applicant address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

Study leader's address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院

Applicant's institution:

West China Hospital of Sichuan University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019年 审(127)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理委员会

Name of the ethic committee:

Biomedical Ethics Committee of West China Hospital, Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2019-02-28 00:00:00

伦理委员会联系人:

李娜

Contact Name of the ethic committee:

Na Li

伦理委员会联系地址:

四川省成都市武侯区国学巷37号

Contact Address of the ethic committee:

Room 412, Old 8th Teaching Building, West China Hospital, Sichuan University, 37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital of Sichuan University

研究实施负责(组长)单位地址:

四川省成都市武侯区国学巷37号

Primary sponsor's address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

成都市

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院

具体地址:

四川省成都市武侯区国学巷37号

Institution
hospital:

West China Hospital of Sichuan University

Address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

经费或物资来源:

四川大学华西医院学科卓越发展1·3·5工程项目

Source(s) of funding:

1·3·5 project of West China Hospital, Sichuan University

Target disease:

hypokalemia

Target disease code:

研究类型:

基础科学研究

Study type:

Basic Science

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

通过全外显子基因测序技术对经过临床诊断后病因仍不明确的低钾血症患者进行分子诊断,探索其病因及病种构成,获得单基因致病型低钾血症患病率。  

Objectives of Study:

To explore the etiology and composition of clinically unexplained hypokalemia through molecular diagnosis using whole exon sequencing and obtain the diagnostic yield of monogenic hypokalemia.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

确定的低钾血症(超过两次以上出现低血钾症状时血钾<3.5mmol/L或者不伴低钾血症症状但连续三次以上血钾<3.5mmol/L);低钾血症家族史。

Inclusion criteria

Confirmed hypokalemia (serum potassium levels of <3.5 mmol/L accompanied with symptoms of hypokalemia for more than twice or more than three times consecutive serum potassium levels less than 3.5 mmol/L without symptoms of hypokalemia); positive family history of hypokalemia.

排除标准:

由于继发因素导致的低钾血症,例如胃肠道病变导致的慢性呕吐或腹泻、慢性肾脏病、肾动脉狭窄、原发性醛固酮增多症、库欣综合征、嗜铬细胞瘤、糖尿病酮症酸中毒及药物导致的低血钾等。

Exclusion criteria:

Hypokalemia due to secondary factors, such as chronic vomiting or diarrhea caused by gastrointestinal lesions, chronic kidney disease, renal artery stenosis, primary aldosteronism, Cushing syndrome, pheochromocytoma, diabetic ketoacidosis, and drug-induced potassium loss.

研究实施时间:

Study execute time:

From 2019-01-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-01-01 00:00:00 To 2021-12-31 00:00:00  

干预措施:

Interventions:

组别:

不明原因低钾血症住院患者

样本量:

100

Group:

Clinically unexplained hypokalemia inpatients

Sample size:

干预措施:

不涉及

干预措施代码:

Intervention:

Not Applicable

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川省 

市(区县):

成都市 

Country:

China 

Province:

Sichuan 

City:

Chengdu 

单位(医院):

四川大学华西医院 

单位级别:

三级甲等 

Institution
hospital:

West China Hospital of Sichuan University

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

四川省 

市(区县):

泸州市 

Country:

China 

Province:

Sichuan 

City:

Luzhou 

单位(医院):

西南医科大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

The Affiliated Hospital of Southwest Medical University

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

全外显子测序

指标类型:

主要指标

Outcome:

Whole exon sequencing

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不适用

Randomization Procedure (please state who generates the random number sequence and by what method):

Not Applicable

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

不适用

Blinding:

Not Applicable

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束且项目文章发表后可向本研究单位申请原始数据,批准后可提供原始数据。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The raw data can be assessed upon application for approval from West China Hospital of Sichuan University after the study ends and the relevant research articles are published.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2022-02-05 10:18:46